Jeremiah McDole, Ph.D. is Director of Clinical Research and Development at StemGenex.
Jeremiah is a 2004 graduate of Berea College. In 2009, he earned a Ph.D. in neuroscience from the University of Cincinnati with a focus in neuroimmunology. Through the end of 2012 he continued his education at Washington University in St. Louis School of Medicine as a Postdoctoral Research Associate in the department of Pathology and Immunology.
During his academic science career Jeremiah worked in a broad range of therapeutic areas that targeted multiple human diseases. He has publications related to several disease conditions including multiple sclerosis, encephalitis, stroke, and inflammatory bowel disease.
From 2010-2012 Jeremiah worked with a non-profit consulting organization. As part of this organization he primarily worked with small biotechnology start-ups and early-stage pharmaceutical companies. His work included performing primary and secondary market research as well as new product planning.
Through early 2014 Jeremiah worked as an associate consultant in the business development branch of Viscadia, Inc., a management consulting firm focused on serving specialty pharmaceutical companies via a uniquely analytical approach. His work included new product planning as well as targeting drug products and companies for acquisition.
As Director of Clinical Research and Development at StemGenex, Jeremiah is responsible for project planning and operational delivery of clinical programs, project management, scheduling and budgeting, and overall management, administration, and operation of the laboratory.
Jeremiah currently resides in Del Mar, California.